The global Pemetrexed Drug market size was valued at US$ 1.23 billion in 2024 and is projected to reach US$ 1.56 billion by 2030, at a CAGR of 4.0% during the forecast period 2024-2030.
United States Pemetrexed Drug market size was valued at US$ 401 million in 2024 and is projected to reach US$ 489 million by 2030, at a CAGR of 3.4% during the forecast period 2024-2030.
Chemotherapy drug used to treat non-small cell lung cancer and pleural mesothelioma.
Steady growth supported by increasing cancer incidence and expanding indications. Generic entry in some markets impacting pricing and market dynamics. Ongoing research into combination therapies with immunotherapies.
Report Overview
Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.
This report provides a deep insight into the global Pemetrexed Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pemetrexed Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pemetrexed Drug market in any manner.
Global Pemetrexed Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Eli Lilly and Company
- Pfizer
- Teva
- Eagle Pharmaceuticals
- APOTEX
- Qilu Pharmaceutical
- Biocon
Market Segmentation (by Type)
- 100 mg lyophilized powder/vial
- 500 mg lyophilized powder/vial
Market Segmentation (by Application)
- Pleural mesothelioma
- Non-small cell lung cancer
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Pemetrexed Drug Market
- Overview of the regional outlook of the Pemetrexed Drug Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pemetrexed Drug
1.2 Key Market Segments
1.2.1 Pemetrexed Drug Segment by Type
1.2.2 Pemetrexed Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pemetrexed Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Pemetrexed Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pemetrexed Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pemetrexed Drug Market Competitive Landscape
3.1 Global Pemetrexed Drug Sales by Manufacturers (2019-2024)
3.2 Global Pemetrexed Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Pemetrexed Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pemetrexed Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pemetrexed Drug Sales Sites, Area Served, Product Type
3.6 Pemetrexed Drug Market Competitive Situation and Trends
3.6.1 Pemetrexed Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pemetrexed Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Pemetrexed Drug Industry Chain Analysis
4.1 Pemetrexed Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pemetrexed Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Pemetrexed Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pemetrexed Drug Sales Market Share by Type (2019-2024)
6.3 Global Pemetrexed Drug Market Size Market Share by Type (2019-2024)
6.4 Global Pemetrexed Drug Price by Type (2019-2024)
7 Pemetrexed Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pemetrexed Drug Market Sales by Application (2019-2024)
7.3 Global Pemetrexed Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Pemetrexed Drug Sales Growth Rate by Application (2019-2024)
8 Pemetrexed Drug Market Segmentation by Region
8.1 Global Pemetrexed Drug Sales by Region
8.1.1 Global Pemetrexed Drug Sales by Region
8.1.2 Global Pemetrexed Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Pemetrexed Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pemetrexed Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pemetrexed Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pemetrexed Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pemetrexed Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Eli Lilly and Company
9.1.1 Eli Lilly and Company Pemetrexed Drug Basic Information
9.1.2 Eli Lilly and Company Pemetrexed Drug Product Overview
9.1.3 Eli Lilly and Company Pemetrexed Drug Product Market Performance
9.1.4 Eli Lilly and Company Business Overview
9.1.5 Eli Lilly and Company Pemetrexed Drug SWOT Analysis
9.1.6 Eli Lilly and Company Recent Developments
9.2 Pfizer
9.2.1 Pfizer Pemetrexed Drug Basic Information
9.2.2 Pfizer Pemetrexed Drug Product Overview
9.2.3 Pfizer Pemetrexed Drug Product Market Performance
9.2.4 Pfizer Business Overview
9.2.5 Pfizer Pemetrexed Drug SWOT Analysis
9.2.6 Pfizer Recent Developments
9.3 Teva
9.3.1 Teva Pemetrexed Drug Basic Information
9.3.2 Teva Pemetrexed Drug Product Overview
9.3.3 Teva Pemetrexed Drug Product Market Performance
9.3.4 Teva Pemetrexed Drug SWOT Analysis
9.3.5 Teva Business Overview
9.3.6 Teva Recent Developments
9.4 Eagle Pharmaceuticals
9.4.1 Eagle Pharmaceuticals Pemetrexed Drug Basic Information
9.4.2 Eagle Pharmaceuticals Pemetrexed Drug Product Overview
9.4.3 Eagle Pharmaceuticals Pemetrexed Drug Product Market Performance
9.4.4 Eagle Pharmaceuticals Business Overview
9.4.5 Eagle Pharmaceuticals Recent Developments
9.5 APOTEX
9.5.1 APOTEX Pemetrexed Drug Basic Information
9.5.2 APOTEX Pemetrexed Drug Product Overview
9.5.3 APOTEX Pemetrexed Drug Product Market Performance
9.5.4 APOTEX Business Overview
9.5.5 APOTEX Recent Developments
9.6 Qilu Pharmaceutical
9.6.1 Qilu Pharmaceutical Pemetrexed Drug Basic Information
9.6.2 Qilu Pharmaceutical Pemetrexed Drug Product Overview
9.6.3 Qilu Pharmaceutical Pemetrexed Drug Product Market Performance
9.6.4 Qilu Pharmaceutical Business Overview
9.6.5 Qilu Pharmaceutical Recent Developments
9.7 Biocon
9.7.1 Biocon Pemetrexed Drug Basic Information
9.7.2 Biocon Pemetrexed Drug Product Overview
9.7.3 Biocon Pemetrexed Drug Product Market Performance
9.7.4 Biocon Business Overview
9.7.5 Biocon Recent Developments
10 Pemetrexed Drug Market Forecast by Region
10.1 Global Pemetrexed Drug Market Size Forecast
10.2 Global Pemetrexed Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pemetrexed Drug Market Size Forecast by Country
10.2.3 Asia Pacific Pemetrexed Drug Market Size Forecast by Region
10.2.4 South America Pemetrexed Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pemetrexed Drug by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Pemetrexed Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pemetrexed Drug by Type (2025-2030)
11.1.2 Global Pemetrexed Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pemetrexed Drug by Type (2025-2030)
11.2 Global Pemetrexed Drug Market Forecast by Application (2025-2030)
11.2.1 Global Pemetrexed Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Pemetrexed Drug Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pemetrexed Drug Market Size Comparison by Region (M USD)
Table 5. Global Pemetrexed Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Pemetrexed Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pemetrexed Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pemetrexed Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pemetrexed Drug as of 2022)
Table 10. Global Market Pemetrexed Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pemetrexed Drug Sales Sites and Area Served
Table 12. Manufacturers Pemetrexed Drug Product Type
Table 13. Global Pemetrexed Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pemetrexed Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pemetrexed Drug Market Challenges
Table 22. Global Pemetrexed Drug Sales by Type (Kilotons)
Table 23. Global Pemetrexed Drug Market Size by Type (M USD)
Table 24. Global Pemetrexed Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Pemetrexed Drug Sales Market Share by Type (2019-2024)
Table 26. Global Pemetrexed Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Pemetrexed Drug Market Size Share by Type (2019-2024)
Table 28. Global Pemetrexed Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Pemetrexed Drug Sales (Kilotons) by Application
Table 30. Global Pemetrexed Drug Market Size by Application
Table 31. Global Pemetrexed Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Pemetrexed Drug Sales Market Share by Application (2019-2024)
Table 33. Global Pemetrexed Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Pemetrexed Drug Market Share by Application (2019-2024)
Table 35. Global Pemetrexed Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Pemetrexed Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Pemetrexed Drug Sales Market Share by Region (2019-2024)
Table 38. North America Pemetrexed Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Pemetrexed Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Pemetrexed Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Pemetrexed Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Pemetrexed Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Eli Lilly and Company Pemetrexed Drug Basic Information
Table 44. Eli Lilly and Company Pemetrexed Drug Product Overview
Table 45. Eli Lilly and Company Pemetrexed Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Eli Lilly and Company Business Overview
Table 47. Eli Lilly and Company Pemetrexed Drug SWOT Analysis
Table 48. Eli Lilly and Company Recent Developments
Table 49. Pfizer Pemetrexed Drug Basic Information
Table 50. Pfizer Pemetrexed Drug Product Overview
Table 51. Pfizer Pemetrexed Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Pfizer Business Overview
Table 53. Pfizer Pemetrexed Drug SWOT Analysis
Table 54. Pfizer Recent Developments
Table 55. Teva Pemetrexed Drug Basic Information
Table 56. Teva Pemetrexed Drug Product Overview
Table 57. Teva Pemetrexed Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Teva Pemetrexed Drug SWOT Analysis
Table 59. Teva Business Overview
Table 60. Teva Recent Developments
Table 61. Eagle Pharmaceuticals Pemetrexed Drug Basic Information
Table 62. Eagle Pharmaceuticals Pemetrexed Drug Product Overview
Table 63. Eagle Pharmaceuticals Pemetrexed Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Eagle Pharmaceuticals Business Overview
Table 65. Eagle Pharmaceuticals Recent Developments
Table 66. APOTEX Pemetrexed Drug Basic Information
Table 67. APOTEX Pemetrexed Drug Product Overview
Table 68. APOTEX Pemetrexed Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. APOTEX Business Overview
Table 70. APOTEX Recent Developments
Table 71. Qilu Pharmaceutical Pemetrexed Drug Basic Information
Table 72. Qilu Pharmaceutical Pemetrexed Drug Product Overview
Table 73. Qilu Pharmaceutical Pemetrexed Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Qilu Pharmaceutical Business Overview
Table 75. Qilu Pharmaceutical Recent Developments
Table 76. Biocon Pemetrexed Drug Basic Information
Table 77. Biocon Pemetrexed Drug Product Overview
Table 78. Biocon Pemetrexed Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Biocon Business Overview
Table 80. Biocon Recent Developments
Table 81. Global Pemetrexed Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 82. Global Pemetrexed Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 83. North America Pemetrexed Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 84. North America Pemetrexed Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 85. Europe Pemetrexed Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 86. Europe Pemetrexed Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 87. Asia Pacific Pemetrexed Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 88. Asia Pacific Pemetrexed Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 89. South America Pemetrexed Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 90. South America Pemetrexed Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 91. Middle East and Africa Pemetrexed Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 92. Middle East and Africa Pemetrexed Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 93. Global Pemetrexed Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 94. Global Pemetrexed Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 95. Global Pemetrexed Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 96. Global Pemetrexed Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 97. Global Pemetrexed Drug Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Pemetrexed Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pemetrexed Drug Market Size (M USD), 2019-2030
Figure 5. Global Pemetrexed Drug Market Size (M USD) (2019-2030)
Figure 6. Global Pemetrexed Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pemetrexed Drug Market Size by Country (M USD)
Figure 11. Pemetrexed Drug Sales Share by Manufacturers in 2023
Figure 12. Global Pemetrexed Drug Revenue Share by Manufacturers in 2023
Figure 13. Pemetrexed Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pemetrexed Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pemetrexed Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pemetrexed Drug Market Share by Type
Figure 18. Sales Market Share of Pemetrexed Drug by Type (2019-2024)
Figure 19. Sales Market Share of Pemetrexed Drug by Type in 2023
Figure 20. Market Size Share of Pemetrexed Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Pemetrexed Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pemetrexed Drug Market Share by Application
Figure 24. Global Pemetrexed Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Pemetrexed Drug Sales Market Share by Application in 2023
Figure 26. Global Pemetrexed Drug Market Share by Application (2019-2024)
Figure 27. Global Pemetrexed Drug Market Share by Application in 2023
Figure 28. Global Pemetrexed Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pemetrexed Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Pemetrexed Drug Sales Market Share by Country in 2023
Figure 32. U.S. Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Pemetrexed Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Pemetrexed Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Pemetrexed Drug Sales Market Share by Country in 2023
Figure 37. Germany Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Pemetrexed Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Pemetrexed Drug Sales Market Share by Region in 2023
Figure 44. China Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Pemetrexed Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Pemetrexed Drug Sales Market Share by Country in 2023
Figure 51. Brazil Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Pemetrexed Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Pemetrexed Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Pemetrexed Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Pemetrexed Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Pemetrexed Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pemetrexed Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pemetrexed Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Pemetrexed Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Pemetrexed Drug Market Share Forecast by Application (2025-2030)
